Jinhai Medical Technology FY2025 loss per share narrows 5.71% to S$(0.33); revenue falls 7.89% to S$46 million

Reuters03-27

Jinhai Medical Technology FY2025 loss per share narrows 5.71% to S$(0.33); revenue falls 7.89% to S$46 million

Jinhai Medical Technology published an annual results announcement for the year ended Dec. 31, 2025.
Revenue fell 7.89% to SGD 46.3 million, while loss for the year narrowed 4.71% to SGD 17.4 million.
Gross profit declined 37.37% to SGD 7.2 million, and gross profit margin decreased to 15.5% from 22.8%.
Bank and cash balances rose more than doubled to SGD 35.6 million, following the issuance of 120,000,000 new shares at HKD 1.35 per share for gross proceeds of HKD 162.0 million.
Management said it will allocate resources toward minimally invasive surgery solutions and medical products, while implementing tighter cost controls amid geopolitical and economic uncertainty.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jinhai Medical Technology Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260327-12075195), on March 27, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2622252873?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-27 23:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2622252873","market":"us","top_or_hot":-1,"title":"Jinhai Medical Technology FY2025 loss per share narrows 5.71% to S$(0.33); revenue falls 7.89% to S$46 million","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Jinhai Medical Technology FY2025 loss per share narrows 5.71% to S$(0.33); revenue falls 7.89% to S$46 million\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<ul>\n<li>\n          Jinhai Medical Technology published an annual results announcement for the year ended Dec. 31, 2025.\n        </li>\n<li>\n          Revenue fell 7.89% to SGD 46.3 million, while loss for the year narrowed 4.71% to SGD 17.4 million.\n        </li>\n<li>\n          Gross profit declined 37.37% to SGD 7.2 million, and gross profit margin decreased to 15.5% from 22.8%.\n        </li>\n<li>\n          Bank and cash balances rose more than doubled to SGD 35.6 million, following the issuance of 120,000,000 new shares at HKD 1.35 per share for gross proceeds of HKD 162.0 million.\n        </li>\n<li>\n          Management said it will allocate resources toward minimally invasive surgery solutions and medical products, while implementing tighter cost controls amid geopolitical and economic uncertainty.\n        </li>\n</ul>\n<br/>\n<br/>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jinhai Medical Technology Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260327-12075195), on March 27, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Jinhai Medical Technology FY2025 loss per share narrows 5.71% to S$(0.33); revenue falls 7.89% to S$46 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJinhai Medical Technology FY2025 loss per share narrows 5.71% to S$(0.33); revenue falls 7.89% to S$46 million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-03-27 23:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Jinhai Medical Technology FY2025 loss per share narrows 5.71% to S$(0.33); revenue falls 7.89% to S$46 million\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<ul>\n<li>\n          Jinhai Medical Technology published an annual results announcement for the year ended Dec. 31, 2025.\n        </li>\n<li>\n          Revenue fell 7.89% to SGD 46.3 million, while loss for the year narrowed 4.71% to SGD 17.4 million.\n        </li>\n<li>\n          Gross profit declined 37.37% to SGD 7.2 million, and gross profit margin decreased to 15.5% from 22.8%.\n        </li>\n<li>\n          Bank and cash balances rose more than doubled to SGD 35.6 million, following the issuance of 120,000,000 new shares at HKD 1.35 per share for gross proceeds of HKD 162.0 million.\n        </li>\n<li>\n          Management said it will allocate resources toward minimally invasive surgery solutions and medical products, while implementing tighter cost controls amid geopolitical and economic uncertainty.\n        </li>\n</ul>\n<br/>\n<br/>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jinhai Medical Technology Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260327-12075195), on March 27, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02225","symbol_name":"今海医疗科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nNDLVYwwT:1","article_id":"2622252873","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2622252873","pubTimestamp":1774623928,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Jinhai Medical Technology published an annual results announcement for the year ended Dec. 31, 2025.Revenue fell 7.89% to SGD 46.3 million, while loss for the year narrowed 4.71% to SGD 17.4 million.Gross profit declined 37.37% to SGD 7.2 million, and gross profit margin decreased to 15.5% from 22.8%.Bank and cash balances rose more than doubled to SGD 35.6 million, following the issuance of 120,000,000 new shares at HKD 1.35 per share for gross proceeds of HKD 162.0 million.Management said it will allocate resources toward minimally invasive surgery solutions and medical products, while implementing tighter cost controls amid geopolitical and economic uncertainty.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jinhai Medical Technolog","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02225":"今海医疗科技","BK1150":"人力资源与就业服务"},"translate_title":"金海医疗科技2025财年每股亏损收窄5.71%至新元（0.33）；收入下降7.89%至4600万新元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02225":0.9},"content_text":"Jinhai Medical Technology FY2025 loss per share narrows 5.71% to S$(0.33); revenue falls 7.89% to S$46 million\n    \n\n\n          Jinhai Medical Technology published an annual results announcement for the year ended Dec. 31, 2025.\n        \n\n          Revenue fell 7.89% to SGD 46.3 million, while loss for the year narrowed 4.71% to SGD 17.4 million.\n        \n\n          Gross profit declined 37.37% to SGD 7.2 million, and gross profit margin decreased to 15.5% from 22.8%.\n        \n\n          Bank and cash balances rose more than doubled to SGD 35.6 million, following the issuance of 120,000,000 new shares at HKD 1.35 per share for gross proceeds of HKD 162.0 million.\n        \n\n          Management said it will allocate resources toward minimally invasive surgery solutions and medical products, while implementing tighter cost controls amid geopolitical and economic uncertainty.\n        \n\n\n\n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jinhai Medical Technology Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260327-12075195), on March 27, 2026, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2622252873","isCrawlerRequest":true}